Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease rheumatoid arthritis
Comorbidity C0024314|lymphoproliferative disorder
Sentences 5
PubMedID- 23269079 Successful treatment of immunodeficiency-associated ebv-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration.
PubMedID- 24498893 Objective: to investigate the incidence and clinical features of methotrexate (mtx)-related lymphoproliferative disorders (mtx-lpds) in patients with rheumatoid arthritis (ra).
PubMedID- 21830047 rheumatoid arthritis complicated with immunodeficiency-associated lymphoproliferative disorders during treatment with adalimumab.
PubMedID- 23560463 Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, epstein-barr virus, and clonality are important predictors of disease progression and regression.
PubMedID- 24684409 Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.

Page: 1